Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa

Int J Dermatol. 2020 Mar;59(3):e73-e74. doi: 10.1111/ijd.14674. Epub 2019 Oct 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / adverse effects*
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Antinuclear / blood
  • Antibodies, Antinuclear / immunology
  • Drug Substitution
  • Hidradenitis Suppurativa / drug therapy*
  • Hidradenitis Suppurativa / immunology
  • Humans
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / chemically induced
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / immunology*
  • Male
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / immunology
  • Ustekinumab / therapeutic use
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • Ustekinumab
  • Adalimumab